Merl Charles, MD

Endocrinologist

Clinics

Lipid Practice
400 Parnassus Ave., Suite A-550
San Francisco, CA 94143
Phone: (415) 353–2350
Fax: (415) 353–2337

Hours: Monday to Friday, 8:30 a.m. – 5 p.m.

Academic Title

Professor

More about Merl Charles

Education

University of California Irvine School of Medicine 1967

Residencies

Walter Reed Army Medical Center 1970

Fellowships

UCSF Medical Center 1975

Selected Research and Publications

  1. Zhang M, Charles R, Tong H, Zhang L, Patel M, Wang F, Rames M, Rye KA, Qiu X, Johns DG, Charles MA, Ren G.. HDL surface lipids mediate CETP binding as revealed by electron microscopy and molecular dynamics simulation. Scientific Reports. 2015; 5:8741.
  2. Charles MA, Kane JP. New molecular insights into CETP structure and function: a review. J Lipid Res. 2012 Aug; 53(8):1451-8.
  3. Zhang L, Yan F, Zhang S, Lei D, Charles MA, Cavigiolio G, Oda M, Krauss RM, Weisgraber KH, Rye KA, Pownall HJ, Qiu X, Ren G. Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nat Chem Biol. 2012 Feb 19; 8(4):342-9.
  4. Van J. Pan J. Charles MA. Krauss R. Wong N. Wu X. . Atherogenic lipid phenotype in a general group of subjects. Arch Pathol Lab Med 131:1679-1685,. 2007.
  5. Van J, Pan J, Wasty T, Chan E, Wu X, and Charles MA. . Am J Cardiol. Comparison of Extended Release Niacin and Atorvastatin Monotherapies, and Combination Treatment of the Atherogenic Lipid Profile in Diabetes. 2002; 89:1306-1308.
  6. Pan J, Shilian P, Wu X, Kane JP, Malloy MJ, Charles MA. 2010 Metabolism. 60:292-297. Preß-1 HDL in Diabetes before and after Niacin.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.